Cargando…

Cost-effectiveness of carbapenem-resistant Enterobacteriaceae (CRE) surveillance in Maryland

OBJECTIVE: We analyzed the efficacy, cost, and cost-effectiveness of predictive decision-support systems based on surveillance interventions to reduce the spread of carbapenem-resistant Enterobacteriaceae (CRE). DESIGN: We developed a computational model that included patient movement between acute-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Gary, Tseng, Katie K., Gatalo, Oliver, Martinez, Diego A., Hinson, Jeremiah S., Milstone, Aaron M., Levin, Scott, Klein, Eili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023597/ https://www.ncbi.nlm.nih.gov/pubmed/34674791 http://dx.doi.org/10.1017/ice.2021.361

Ejemplares similares

354 Six Months of Surveillance for Carbapenem-Resistant Enterobacteriaceae in Maryland
por: Vaeth, Elisabeth, et al.
Publicado: (2014)

Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China
por: Zhang, Rong, et al.
Publicado: (2017)

577. The Role of Healthcare Worker-Mediated Contact Networks in the Transmission of Vancomycin-Resistant Enterococci
por: Klein, Eili, et al.
Publicado: (2019)

Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections
por: Suay-García, Beatriz, et al.
Publicado: (2019)

Associations between phone mobility data and COVID-19 cases
por: Gatalo, Oliver, et al.
Publicado: (2021)

1432. Population-based Surveillance of Carbapenem-Resistant Enterobacteriaceae (CRE) in Alameda County, 2017-2020
por: Horwich-Scholefield, Sam, et al.
Publicado: (2020)

1761. Effect of Carbapenem-Resistant Enterobacteriaceae (CRE) Surveillance Case Definition Change on CRE Epidemiology—Selected US Sites, 2015–2016
por: Duffy, Nadezhda, et al.
Publicado: (2018)

537. Impact of Active Surveillance Testing (AST) on Rates of Hospital-acquired Carbapenem-Resistant Enterobacteriaceae (CRE)
por: Campbell, Eileen, et al.
Publicado: (2019)

359 Epidemiology of Carbapenem-Resistant Enterobacteriaceae (CRE) at an Academic Medical Center
por: Leiner, Charles, et al.
Publicado: (2014)

1249. Emergence of Diverse Carbapenem-Resistant Enterobacteriaceae (CRE) in the Dominican Republic
por: Fermin, Rita Rojas, et al.
Publicado: (2018)

499. Carbapenem-resistant Enterobacteriaceae (CRE)-associated Infections and Prolonged Colonization among Hospitalized Patients Colonized by CRE
por: Khawcharoenporn, Thana, et al.
Publicado: (2019)

533. Impact of Different Definitions on Reported Rates of Carbapenem-Resistant Enterobacteriaceae (CRE)
por: Passaretti, Catherine, et al.
Publicado: (2019)

509. The Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) in a Community Hospital Setting
por: Lewis, Sally, et al.
Publicado: (2019)

843. Increased Carbapenemase Testing Following Implementation of VA Guidelines for Carbapenem-Resistant Enterobacteriaceae (CRE)
por: Fitzpatrick, Margaret A, et al.
Publicado: (2020)

The Role of Healthcare Worker-Mediated Contact Networks in the Transmission of Vancomycin-Resistant Enterococci
por: Klein, Eili Y, et al.
Publicado: (2020)

Reply to Hemmige and David
por: Klein, Eili Y, et al.
Publicado: (2019)

1591. Antibiotic Utilization Trends in Veterans Affairs (VA) Patients with Carbapenem Resistant Enterobacteriaceae (CRE) Infections
por: Traversa, Alfredo, et al.
Publicado: (2020)

Cost-effectiveness analysis of vaborem for the treatment of carbapenem-resistant Enterobacteriaceae-Klebsiella pneumoniae carbapenemase (CRE-KPC) infections in the UK
por: Vlachaki, Ioanna, et al.
Publicado: (2021)

Removal of Carbapenem-Resistant Enterobacteriaceae (CRE) from Blood by Heparin-Functional Hemoperfusion Media
por: McCrea, Keith, et al.
Publicado: (2014)

Comparison of the Performance of Phenotypic Methods for the Detection of Carbapenem-Resistant Enterobacteriaceae (CRE) in Clinical Practice
por: Zhang, Zhijie, et al.
Publicado: (2022)

Bacterial characteristics of carbapenem-resistant Enterobacteriaceae (CRE) colonized strains and their correlation with subsequent infection
por: Lin, Qun, et al.
Publicado: (2021)

Carbapenem-Resistant Enterobacteriaceae (CRE) among Children with Cancer: Predictors of Mortality and Treatment Outcome
por: Madney, Youssef, et al.
Publicado: (2023)

Endogenous Bacteremia Caused by Intestinal Colonization of Carbapenem-Resistant Enterobacteriaceae (CRE) in Immunocompromised Children
por: Almasian Tehrani, Nasim, et al.
Publicado: (2023)

Carbapenem-resistant Enterobacteriaceae (CRE) and gram-negative bacterial infections in south-west Nigeria: a retrospective epidemiological surveillance study
por: Adesanya, Oluwafolajimi Adetoye, et al.
Publicado: (2020)

Vital Signs: Carbapenem-Resistant Enterobacteriaceae
por: Jacob, Jesse T., et al.
Publicado: (2013)

2450. Antibiotic Treatment for Carbapenem-Resistant Enterobacteriaceae (CRE) and Outcomes in Veterans With Spinal Cord Injury/Disorder (SCI/D)
por: Little, Erica K, et al.
Publicado: (2018)

Epidemiologic Patterns and Clinical Implications of Genotypic Resistance Mechanism for Carbapenem-Resistant Enterobacteriaceae (CRE)Surveillance Isolates from Los Angeles County
por: Bhaurla, Sandeep, et al.
Publicado: (2017)

355 Carbapenem-Resistant Enterobacteriaceae (CRE) Distribution within the Veterans Affairs Healthcare System: 2013
por: Ryono, Russell, et al.
Publicado: (2014)

High burden of Carbapenem-resistant Enterobacteriaceae (CRE) fecal carriage at a teaching hospital: cost-effectiveness of screening in low-resource setting
por: Zaidah, Abdul Rahman, et al.
Publicado: (2017)

CaseFinder: A Flexible Real-time Online Surveillance Registry for Infectious Disease Physicians to Report Cases of Carbapenem-resistant Enterobacteriaceae (CRE)
por: Curtis, Donald, et al.
Publicado: (2013)

525. Evaluation of Implementation of Guidelines for Carbapenem-resistant Enterobacteriaceae (CRE) Prevention Using the Consolidated Framework for Implementation Research (CFIR)
por: Goedken, Cassie, et al.
Publicado: (2019)

532. Can Saccharomyces boulardii Therapy Be Effective in Decolonizing Rectal Carbapenem-Resistant Enterobacteriaceae (CRE) Colonization?
por: Resat Sipahi, Oguz, et al.
Publicado: (2019)

2130. Detection of Carbapenemase-Producing Organisms and Impact on Antimicrobial Utilization for Carbapenem-Resistant Enterobacteriaceae (CRE) Infections
por: Minor, Sarah Brooks, et al.
Publicado: (2019)

2276. Clinical Epidemiology of the Carbapenem-Resistant Enterobacteriaceae (CRE) Epidemic in Colombia: A Multicenter Prospective Study
por: Valderrama-Beltrán, Sandra Liliana, et al.
Publicado: (2019)

Treatment of Ventriculitis and Meningitis After Neurosurgery Caused by Carbapenem-Resistant Enterobacteriaceae (CRE): A Challenging Topic
por: Li, Cuiling, et al.
Publicado: (2023)

1178. A Multicenter Prospective Study of Clinical and Molecular Epidemiological Analysis of Carbapenem-Resistant Enterobacteriaceae (CRE) and Carbapenemase-Producing Enterobacteriaceae (CPE) in Japan
por: Hayakawa, Kayoko, et al.
Publicado: (2018)

Evaluation of carbapenem-resistant Enterobacteriaceae (CRE) guideline implementation in the Veterans Affairs Medical Centers using the consolidated framework for implementation research
por: Goedken, Cassie Cunningham, et al.
Publicado: (2021)

Machine learning and artificial intelligence: applications in healthcare epidemiology
por: Hamilton, Alisa J., et al.
Publicado: (2021)

1726 What Defines Carbapenem-Resistant Enterobacteriaceae (CRE) in a Low Prevalence State? Oregon, 2010 — 2013
por: Maureen Cassidy, P., et al.
Publicado: (2014)

2167. Predicting Carbapenem-Resistant Enterobacteriaceae (CRE) Carriage on Admission using Updated Statewide Hospital Discharge Data
por: Ray, Michael J, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1fd3q0c1s22ukbeod3ra6gba3b